The global medical bone densitometers market is anticipated to grow at a considerable CAGR of 10.7% during the forecast period. The bone densitometer market is growing due to the rising prevalence of osteoarthritis and vitamin deficiencies, increased usage of bone densitometers, and technical developments. According to a paper commissioned by the Arthritis Community, Research and Evaluation Unit (ACREU) titled "The Burden of Osteoarthritis in Canada (2021)," almost 15% of Canadians aged 20 and up have osteoarthritis. According to the report, osteoarthritis affects about 4 million Canadians or nearly one in every seven persons. The high prevalence of these conditions is likely to increase demand for bone densitometers systems for precise diagnosis, resulting in market growth.
Browse the full report description of “Global Medical Bone Densitometers Market Size, Share & Trends Analysis Report by Type (DEXA and Ultrasound), by Technology (Axial Bone Densitometry and Peripheral Bone Densitometry), and by End-User (Hospitals, Medical Institutions, and Others) Forecast Period (2022-2028)” at https://www.omrglobal.com/industry-reports/medical-bone-densitometers-market
The key companies operating in the industry are highly inclined towards the adoption of different growth strategies including capacity expansion, partnerships, mergers and acquisitions, geographical expansion, new product launches, and product innovation to remain competitive in the marketplace. For instance, Aurora Spine Corporation announced in March 2022 that it had conducted the world's first DEXA-C implantation at Louisiana's Cypress Pointe Surgical Hospital, where the implant density was directly matched to the patient's bone quality. Echolight Medical and Aurora Spine Corporation signed a cooperative co-marketing agreement in February 2022. Aurora is working on DEXA Technology-based Spinal Implants, whereas Echolight specializes in non-ionizing radiation bone health assessment. As part of the Aurora DEXA Platform, the two firms agreed to advertise each other's products to their respective customers and prospects. Aurora can use Echolight's bone health assessment capabilities in conjunction with its DEXA Technology-based patient-matched implants, and Echolight can market and publicize Echolight's devices to determine which of Aurora's DEXA Technology implants is ideal for each patient's bone quality, whether normal, osteopenia, or osteoporotic.
Market Coverage
Segment Covered-
Regions Covered-
Competitive Landscape- Medtronic PLC, Koninklijke Phillips NV, Boston Scientific Corp., Abbott Laboratories Inc., and Johnson & Johnson Services, Inc. among others.
Key questions addressed by the report
oDeviation from the pre-COVID-19 forecast
oMost affected region and segment
Global Medical Bone Densitometers Market Report Segment
By Type
By Technology
By End-User
Global Medical Bone Densitometers Market Report Segment by Region
North America
Europe
Asia-Pacific
Rest of the World
To learn more about this report request a free sample copy @ https://www.omrglobal.com/industry-reports/medical-bone-densitometers-market